Skip to content

4891.T

TMS Co.,Ltd.

グロース · 医薬品 · 医薬品 · JP

JPY 107.00
−0.93%
Ask drillr

Income statement

MetricTTM2025202520242023
Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
R&D Expense
SG&A Expense
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses
Cost and Expenses
Operating Income (EBIT)(899.0M)(696.0M)(907.0M)(943.0M)(520.0M)
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense(14.6M)(14.6M)274.8M(142.0K)(341.3M)
Non-Operating Income (excl Interest)14.0K83.0K1.0K
EBT (Pre-Tax Income)(919.3M)(715.3M)(659.6M)(959.1M)(861.5M)
Income Tax Expense1.0M791.0K950.0K950.0K(545.0K)
Bottom Line
Net Income(920.0M)(716.0M)(660.0M)(960.0M)(860.0M)
Earnings from Cont. Ops
Earnings from Discont. Ops
Bottom Line Net Income(920.0M)(716.0M)(660.0M)(960.0M)(860.0M)
Per Share
Basic EPS(¥21)(¥16)(¥16)(¥26)(¥25)
Diluted EPS(¥21)
Revenue Per Share
Shares
Basic Shares Outstanding45.5M44.5M40.3M36.9M34.1M
Diluted Shares Outstanding
Profitability Metrics
EBITDA(421.7M)(695.7M)(903.3M)(936.0M)(513.4M)
D&A262.0K262.0K3.7M7.0M6.6M
EBIT(899.0M)(696.0M)(907.0M)(943.0M)(520.0M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026